Latest High-intensity focused ultrasound Stories
CORAL SPRINGS, Fla., Oct. 31, 2011 /PRNewswire/ -- Prostate cancer patient advocate Dr. Bert Vorstman cautions men diagnosed with an elevated PSA (prostatic specific antigen or tPSA) through a routine blood test from being steered towards aggressive treatments that could leave them impotent and incontinent. A government panel--The United States Preventative Task Force--recently issued a statement that men should no longer get screened for prostate cancer, as they found the tPSA blood test...
HAYWARD, Calif., Oct. 24, 2011 /PRNewswire/ -- Solta Medical, Inc. (Solta) (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced that Medicis Technologies Corporation (formerly LipoSonix, Inc.), a subsidiary of Medicis Pharmaceutical Corporation (Medicis) has received U.S. Food and Drug Administration (FDA) clearance of the second generation LipoSonix system specifically indicated for non-invasive waist circumference reduction. The LipoSonix system delivers high...
NEW YORK, Oct. 21, 2011 /PRNewswire/ -- Dr. David Samadi, Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center, routinely encourages patients to explore all prostate cancer treatment options. Though he firmly believes in the success and benefits of robotic prostatectomy, he knows the decision for prostate cancer surgery does not come easy. "I want my patients to do their homework," he says. "This is a life-saving...
Renown urologist, Peter Sinaiko, MD FACS, launches new blog to educate patients, medical professionals and regulators about the efficacy of HIFU therapy for treatment of prostate cancer. The blog is located at http://www.hifuprostatecancerdoctor.com. Langhorne, PA (PRWEB) October 20, 2011 Sinako Urology, led by Peter Sinako, MD FACS, announced that it has launched a website and blog dedicated to the coverage of High Intensity Focused Ultrasound or HIFU for the treatment of prostate cancer...
CHICAGO, Oct. 19, 2011 /PRNewswire/ -- ICAP Patent Brokerage, a division of ICAP plc, the world's largest intellectual property brokerage and patent auction firm, is offering for sale seven patent portfolios from a major medical device company. The available portfolios disclose patented technology related to biomaterials, bio-prosthetics, device failure control, high-intensity focused ultrasound (HIFU) energy, improved blood management, medical devices and suction ablation. (Logo:...
Results of first-in-world study could open doors to treating other brain disorders WASHINGTON, Oct. 3, 2011 /PRNewswire-USNewswire/ -- In a presentation at the Congress of Neurological Surgeons today, University of Virginia neurosurgeon W. Jeffrey Elias, MD reported that preliminary results of a pilot clinical trial indicate that MR-guided focused ultrasound has the potential to safely and effectively control essential tremor (ET), a common neurological condition that affects 10...
CLEVELAND, Sept. 29, 2011 /PRNewswire/ -- ViewRay(TM), Inc., a privately held medical device company, will present potential applications for MRI-guided radiotherapy at the annual meeting of the American Society for Radiation Oncology (ASTRO) October 2 - 4 in Miami Beach, Florida, with software demonstrations in booth #865. The company's new research radiation therapy system is being developed to feature a patented combination of radiotherapy delivery and simultaneous magnetic resonance...
SAN DIEGO, Sept. 21, 2011 /PRNewswire/ -- MedWaves' AveCure(TM) microwave coagulation-ablation (MWA) system uses microwave energy to volumetrically coagulate-ablate (destroy) soft-tissue lesions (abnormal structures) safely, effectively, precisely and with repeatability. The system has successfully treated over 1,000 patients worldwide, including lesions in bone, kidney, liver, lung and pancreas. The Company plans to bring its technology to treat lesions in other locations in the body. The...
TIRAT CARMEL, Israel, September 21, 2011 /PRNewswire/ -- InSightec Ltd., the global leader in MR guided Focused Ultrasound (MRgFUS) technology, announced today that its investigational ExAblate(R) Neuro system has been used in clinical studies to treat 30 patients suffering from chronic neurological disorders. The clinical trials are being conducted by functional neurosurgeons, neurologists and neuroradiologists in Switzerland, and the US to evaluate the safety and initial...
CHARLOTTESVILLE, Va., Sept. 20, 2011 /PRNewswire-USNewswire/ -- The Focused Ultrasound Surgery (FUS) Foundation has announced the selection of Wladyslaw Gedroyc, MD of Imperial College and Saint Mary's Hospital in London as Honorary President of the 3rd International Symposium on MR-guided Focused Ultrasound. A consultant radiologist, Gedroyc is recognized worldwide as a pioneer in the development of noninvasive patient treatments using MR-guided focused ultrasound. Much of Gedroyc's...
